7.14
price down icon1.11%   -0.08
after-market アフターアワーズ: 7.07 -0.07 -0.98%
loading
前日終値:
$7.22
開ける:
$7.12
24時間の取引高:
33,345
Relative Volume:
0.10
時価総額:
$5.93M
収益:
-
当期純損益:
$-14.93M
株価収益率:
-0.0268
EPS:
-266.137
ネットキャッシュフロー:
$-15.87M
1週間 パフォーマンス:
+5.15%
1か月 パフォーマンス:
-29.58%
6か月 パフォーマンス:
-96.70%
1年 パフォーマンス:
-99.42%
1日の値動き範囲:
Value
$7.0201
$7.46
1週間の範囲:
Value
$6.80
$8.18
52週間の値動き範囲:
Value
$6.1478
$1,293.51

Transcode Therapeutics Inc Stock (RNAZ) Company Profile

Name
名前
Transcode Therapeutics Inc
Name
セクター
Healthcare (1171)
Name
電話
857-301-6857
Name
住所
6 LIBERTY SQUARE, BOSTON
Name
職員
7
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
RNAZ's Discussions on Twitter

RNAZ を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RNAZ
Transcode Therapeutics Inc
7.14 5.75M 0 -14.93M -15.87M -266.14
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.232 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.34 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 65.36B 14.09B 4.50B 2.96B 39.28

Transcode Therapeutics Inc (RNAZ) 最新ニュース

pulisher
May 29, 2025

(RNAZ) On The My Stocks Page - news.stocktradersdaily.com

May 29, 2025
pulisher
May 28, 2025

Transcode Therapeutics Appoints Dr. Phillip D. Zamore To Science Advisory Board - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board - citybiz

May 28, 2025
pulisher
May 28, 2025

TransCode Therapeutics appoints RNA expert to advisory board - Investing.com

May 28, 2025
pulisher
May 28, 2025

TransCode Therapeutics appoints RNA expert to advisory board By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

Alnylam Co-Founder Who Developed First FDA-Approved RNAi Drug Joins TransCode's Cancer Mission - Stock Titan

May 28, 2025
pulisher
May 24, 2025

TransCode Therapeutics (NASDAQ:RNAZ) Cut to “Sell” at Wall Street Zen - Defense World

May 24, 2025
pulisher
May 23, 2025

Certain Options of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Certain Warrants of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Certain Common Stock of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com

May 23, 2025
pulisher
May 19, 2025

When (RNAZ) Moves Investors should Listen - news.stocktradersdaily.com

May 19, 2025
pulisher
May 16, 2025

Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Nkarta (NKTX) and Kamada (KMDA) - The Globe and Mail

May 16, 2025
pulisher
May 14, 2025

Transcode Therapeutics (RNAZ) Trading Halted Pending News Announ - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Transcode Therapeutics (RNAZ) Trading Halted Pending News Announcement | RNAZ Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

TransCode Therapeutics (RNAZ) Expected to Announce Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Abeona Therapeutics (ABEO) Expected to Announce Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Intellia Therapeutics (NASDAQ:NTLA) Shares Down 6.1% After Analyst Downgrade - Defense World

May 14, 2025
pulisher
May 12, 2025

Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested - The Globe and Mail

May 12, 2025
pulisher
May 09, 2025

(RNAZ) Investment Report - news.stocktradersdaily.com

May 09, 2025
pulisher
May 08, 2025

TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported - Stock Titan

May 08, 2025
pulisher
May 07, 2025

TransCode Therapeutics Faces Nasdaq Delisting Risk - TipRanks

May 07, 2025
pulisher
May 05, 2025

TransCode Therapeutics Announces Reverse Stock Split - TipRanks

May 05, 2025
pulisher
May 05, 2025

TransCode Plans Massive 28:1 Stock Consolidation: What This Means for Your RNAZ Shares - Stock Titan

May 05, 2025
pulisher
May 05, 2025

US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Benzinga

May 05, 2025
pulisher
May 05, 2025

Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday - Benzinga

May 05, 2025
pulisher
May 04, 2025

TransCode Therapeutics Announces 1-for-28 Reverse Stock Split - citybiz

May 04, 2025
pulisher
May 03, 2025

TransCode Therapeutics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com India

May 03, 2025
pulisher
May 02, 2025

TransCode Therapeutics (RNAZ) Plans 1-for-28 Reverse Stock Split - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Offerings News Live Feed - Stock Titan

May 02, 2025
pulisher
May 02, 2025

Transcode Therapeutics Announces 1-For-28 Reverse Stock Split - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics (RNAZ) Announces 1-for-28 Reverse Stock Split - GuruFocus

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics approves reverse stock split to meet Nasdaq rules - Investing.com

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics approves 1-for-28 reverse stock split; shares fall - MSN

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics (RNAZ) Plans 1-for-28 Reverse Stock Split | RNAZ Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics to Implement 1-for-28 Reverse Stock Split - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

TransCode Plans Major 1:28 Reverse Split, Slashing Shares from 23M to 833K for Nasdaq Listing - Stock Titan

May 02, 2025
pulisher
May 02, 2025

TransCode Stock Rallies On Promising Metastatic Cancer Drug Trial: Retail Sees More Upside - MSN

May 02, 2025
pulisher
May 02, 2025

For Dropbox Inc [DBX], Analyst sees a drop to $30. What next? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Direct Digital Holdings Inc [DRCT] is -44.37% lower this YTD. Is it still time to buy? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

CN Energy Group Inc [CNEY] Is Currently 9.75 above its 200 Period Moving Avg: What Does This Mean? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Wall Street Analyst Upgrade Rush Street Interactive Inc [RSI]. What else is Wall St. saying - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

why Kronos Bio Inc [KRON] is a Good Choice for Investors After New Price Target of $1.00 - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Glaukos Corporation [GKOS] Revenue clocked in at $383.48 million, down -44.28% YTD: What’s Next? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Republic Digital Acquisition Company [RDAGU] Stock trading around $10.15 per share: What’s Next? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Venture Global Inc [VG] stock Initiated by UBS analyst, price target now $14 - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Hayward Holdings Inc [HAYW] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Market cap of Solaris Energy Infrastructure Inc [SEI] reaches 1.55B – now what? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

why Astera Labs Inc [ALAB] is a Good Choice for Investors After New Price Target of $111.21 - dbtnews.com

May 02, 2025
pulisher
May 01, 2025

IBN Coverage: TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138 - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138 - The Globe and Mail

May 01, 2025
pulisher
May 01, 2025

TransCode Therapeutics (RNAZ) Advances Clinical Trial of TTX-MC1 - GuruFocus

May 01, 2025

Transcode Therapeutics Inc (RNAZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.15
price up icon 0.00%
$585.93
price up icon 0.92%
$300.83
price down icon 2.33%
$38.11
price up icon 4.30%
$4.73
price down icon 1.69%
$493.22
price up icon 2.10%
大文字化:     |  ボリューム (24 時間):